Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care (PNOrate)
Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care: a Retrospective Study in 6 Centers
The number of lung biopsies has increased steadily in recent years. Pneumothorax is the most common complication of a lung biopsy and can occur during the procedure, immediately after the procedure or within a few hours (delayed pneumothorax). The incidence of pneumothorax in the literature is very different from one study to another: it has been reported to be from 9 to 54% in patients undergoing percutaneous transthoracic needle biopsy. This difference of incidence could be explained by the absence of consensus for the definition of an iatrogenic pneumothorax.
The characteristics of pneumothorax and the management of patients with iatrogenic pneumothorax will be evaluated in different centres in a retrospective manner. This study will contribute to refining the criteria for defining pneumothorax occurring during lung biopsy and will provide a better understanding of the condition and its management.
研究概览
研究类型
注册 (预期的)
联系人和位置
学习联系方式
- 姓名:Candice HOUG
- 电话号码:0381218341
- 邮箱:choug@chu-besancon.fr
学习地点
-
-
-
Besançon、法国
- 招聘中
- CHU de Besançon
-
接触:
- Candice HOUG
- 邮箱:choug@chu-besancon.fr
-
首席研究员:
- Julien BEHR, MD
-
Bordeaux、法国
- 招聘中
- Institut Bergonie
-
首席研究员:
- Jean Palussiere, MD
-
Tours、法国
- 招聘中
- CHU de Tours
-
首席研究员:
- Antoine BRAULT, MD
-
Villejuif、法国
- 招聘中
- Institut Gustave Roussy
-
首席研究员:
- Lambros Tselikas, MD
-
-
-
-
-
Dublin、爱尔兰
- 招聘中
- Saint James Hospital
-
首席研究员:
- Peter BEDDY, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Patients aged 18 years old and more at the time of the biopsy procedure in year 2020
- Having had a pneumothorax following their transthoracic percutaneous lung biopsy in year 2020
Exclusion Criteria:
- Objection to the use of the data (French sites only)
学习计划
研究是如何设计的?
设计细节
- 观测模型:仅案例
- 时间观点:追溯
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Annual incidence rate of pneumothorax related to transthoracic lung biopsy on total number of lung biopsies
大体时间:3 months
|
3 months
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Annual incidence rate of hospitalisation in patients with pneumothorax related to lung biopsies
大体时间:3 months
|
3 months
|
|
Annual incidence rate of drainage in patients with pneumothorax related to lung biopsies
大体时间:3 months
|
3 months
|
合作者和调查者
调查人员
- 首席研究员:Julien BEHR, MD、CHU de Besançon
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2021/625
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.